BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Loading...
Loading...

Insights into the oncogenic effects of PIK3CA mutations from the structure of p110alpha p85alpha Pages on BioPortfolio:

BioPortfolio - V. Amzel & Associates
Insights into the oncogenic effects of PIK3CA mutations from the structure of p110alpha/p85alpha. Phosphatidylinositide-3-kinases (PI3K) initiate a number ...
http://www.bioportfolio.com/biocorporate/10718-V._Amzel_&_As...

Results from other life science and pharmaceutical sites:

Insights into the oncogenic effects of PIK3CA muta...[Cell Cycle ...
Insights into the oncogenic effects of PIK3CA mutations from the structure ... The structure of a human p110alpha/p85alpha complex elucidates the effects of
...
http://www.ncbi.nlm.nih.gov/pubmed/18418043...

Oncogene - Class I PI3K in oncogenic cellular transformation
Insights into the oncogenic effects of /PIK3CA/mutations from the structure of p110alpha/p85alpha. Cell Cycle 7: 1151–1156. | PubMed | ChemPort |; Huang CH,
...
http://www.nature.com/onc/journal/v27/n41/full/onc2008244a.h...

The structure of a human p110alpha/p85alpha comple...[Science ...
2007]; Insights into the oncogenic effects of PIK3CA mutations from the structure of p110alpha/p85alpha. [Cell Cycle. 2008]; Positive and negative ...
http://www.ncbi.nlm.nih.gov/pubmed/18079394...

Helical domain and kinase domain mutations in p110α of ...
The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations. Science. 2007;318:1744–1748. [PubMed] ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=22...

The structure of a human p110alpha/p85alpha complex elucidates the ...
The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations. Huang CH, Mandelker D, Schmidt-Kittler O, ...
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=pub...

BioPortfolio - V. Amzel & Associates
Insights into the oncogenic effects of PIK3CA mutations from the structure of p110alpha/p85alpha. Phosphatidylinositide-3-kinases (PI3K) initiate a number ...
http://www.bioportfolio.com/biocorporate/10718-V._Amzel_&_As...

Human tumor mutants in the p110alpha subunit of PI...[Cell Cycle ...
[Proc Natl Acad Sci U S A. 2006]; The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations. [Science. ...
http://www.ncbi.nlm.nih.gov/pubmed/16627990...

Oncogene - Overexpression of p101 activates PI3K[gamma] signaling ...
Oncogenic mutations of PIK3CA in human cancers. Cell Cycle 3: 1221–1224. ... of p110alpha are associated with progression of dysplasia into invasive ...
http://www.nature.com/onc/journal/v26/n49/full/1210504a.html...

Phosphoinositide 3-kinase controls early and late events in ...
The figure shows mutations in p85, p110, PTEN and PKB in human cancer, ..... Sanchez I, Dynlacht BD (2005) New insights into cyclins, CDKs and cell cycle ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=13...

BioMed Central | Full text | Topographical expression of class IA ...
Extensive insight into the PI3K signalling network has been gained through ...... Stahl U: Genomic gain of PIK3CA and increased expression of p110alpha are
...
http://www.biomedcentral.com/1472-6890/3/4...

Google Custom Search

Search
  

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo